Blockchain Registration Transaction Record

Lantern Pharma Raises $4.4M, Spins Out AI Platform withZeta.ai

Lantern Pharma raises $4.4M in registered direct offering and plans to spin out its AI platform withZeta.ai as an independent entity. The company advances its AI-driven precision oncology pipeline.

This news matters because Lantern Pharma is not only advancing its clinical pipeline of cancer therapies but also creating a new revenue stream by spinning out its AI platform withZeta.ai as an independent entity. This move could accelerate the adoption of AI in drug discovery and development, potentially leading to more efficient and targeted cancer treatments. For investors, the offering provides capital to support ongoing trials and expansion, while the commercialization of withZeta.ai opens up a new market for AI-driven biomedical research tools. The success of this strategy could position Lantern as a key player in the convergence of AI and precision oncology.